4
Changes in Ownership
Axsome Therapeutics, Inc. Filed Acc 0001193125-26-083606
Options or other derivatives
- Chief Commercial Officer acquired 16,385 shares (grant or award)
From the SEC's structured data for this filing
Axsome Therapeutics, Inc. Filed Acc 0001193125-26-083606
Options or other derivatives
From the SEC's structured data for this filing
Connection lost
Reconnecting…
Cite Filings isn't responding
Reconnecting…